Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited Settings.
Jennings L, Kellermann T, Spinelli M, Nkantsu Z, Cogill D, van Schalkwyk M, Decloedt E, van Zyl G, Orrell C, Gandhi M. Jennings L, et al. AIDS Res Hum Retroviruses. 2022 Jun;38(6):455-462. doi: 10.1089/AID.2021.0135. Epub 2021 Dec 29. AIDS Res Hum Retroviruses. 2022. PMID: 34779228 Free PMC article.
Patients' and Providers' Views on Optimal Evidence-Based and Scalable Interventions for Individuals at High Risk of HIV Treatment Failure: Sequential Explorations Among Key Stakeholders in Cape Town, South Africa.
Sabin LL, Gifford AL, Haberer JE, Harvey K, Sarkisova N, Martin K, West RL, Stephens J, Killian C, Halim N, Berkowitz N, Jennings K, Jennings L, Orrell C. Sabin LL, et al. Among authors: jennings k, jennings l. AIDS Behav. 2022 Aug;26(8):2783-2797. doi: 10.1007/s10461-022-03623-7. Epub 2022 Feb 21. AIDS Behav. 2022. PMID: 35190943
Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa.
Mukora R, Maraba N, Orrell C, Jennings L, Naidoo P, Mbatha MT, Velen K, Fielding K, Charalambous S, Chetty-Makkan CM. Mukora R, et al. Among authors: jennings l. BMJ Open. 2023 Mar 3;13(3):e065202. doi: 10.1136/bmjopen-2022-065202. BMJ Open. 2023. PMID: 36868589 Free PMC article.
Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors.
Jennings L, Ferraris CM, Castillo-Mancilla JR, Robbins RN, Nguyen N, Leu CS, Dolezal C, Hsiao NY, Mgbako O, Joska J, Myer L, Anderson PL, Remien RH, Orrell C; ADD-ART team. Jennings L, et al. J Acquir Immune Defic Syndr. 2023 Aug 1;93(4):327-332. doi: 10.1097/QAI.0000000000003198. Epub 2023 Mar 24. J Acquir Immune Defic Syndr. 2023. PMID: 36976520 Free PMC article.
Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots: Results from a Pilot Study Among Patients and Providers in Cape Town, South Africa.
Ferraris CM, D'avanzo PA, Jennings L, Robbins RN, Nguyen N, Leu CS, Dolezal C, Mgbako O, Hsiao NY, Joska J, Castillo-Mancilla JR, Myer L, Anderson PL, Belaunzarán-Zamudio PF, Mellins CA, Orrell C, Remien RH. Ferraris CM, et al. Among authors: jennings l. AIDS Behav. 2023 Oct;27(10):3478-3486. doi: 10.1007/s10461-023-04063-7. Epub 2023 Apr 12. AIDS Behav. 2023. PMID: 37043053 Free PMC article. Clinical Trial.
968 results